title: Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage.
abstract: BACKGROUND
  Subarachnoid haemorrhage (SAH) elicits rapid pathological changes in the structure and function of parenchymal vessels (≤ 100 μm). The role of neutrophils in these changes has not been determined. This study investigates the role of neutrophils in early microvascular changes after SAH METHOD: Rats were either untreated, treated with vinblastine or anti-polymorphonuclear (PMN) serum, which depletes neutrophils, or treated with pyrrolidine dithiocarbamate (PDTC), which limits neutrophil activity. SAH was induced by endovascular perforation. Neutrophil infiltration and the integrity of vascular endothelium and basement membrane were assessed immunohistochemically. Vascular collagenase activity was assessed by in situ zymography.
  
  
  RESULTS
  Vinblastine and anti-PMN serum reduced post-SAH accumulation of neutrophils in cerebral vessels and in brain parenchyma. PDTC increased the neutrophil accumulation in cerebral vessels and decreased accumulation in brain parenchyma. In addition, each of the three agents decreased vascular collagenase activity and post-SAH loss of vascular endothelial and basement membrane immunostaining.
  
  
  CONCLUSIONS
  Our results implicate neutrophils in early microvascular injury after SAH and indicate that treatments which reduce neutrophil activity can be beneficial in limiting microvascular injury and increasing survival after SAH.
authors.affiliation: Department of Neuroscience, Mount Sinai School of Medicine, New York, NY 10029, USA.
authors.forename: Victor
authors.initials: V
authors.lastname: Friedrich
authors.forename: Rowena
authors.initials: R
authors.lastname: Flores
authors.forename: Artur
authors.initials: A
authors.lastname: Muller
authors.forename: Weina
authors.initials: W
authors.lastname: Bi
authors.forename: Ellinor Ib
authors.initials: EI
authors.lastname: Peerschke
authors.forename: Fatima A
authors.initials: FA
authors.lastname: Sehba
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism / Q000494:pharmacology; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D002199:Capillary Permeability; D004730:Endothelium, Vascular / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008297:Male; D008833:Microcirculation; D018375:Neutrophil Activation; D020556:Neutrophil Infiltration; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D011392:Proline / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013345:Subarachnoid Hemorrhage / Q000473:pathology* / Q000503:physiopathology; D013859:Thiocarbamates / Q000378:metabolism / Q000494:pharmacology; D050257:Tubulin Modulators / Q000494:pharmacology; D014747:Vinblastine / Q000494:pharmacology
chemical_list: D000975:Antioxidants; D015415:Biomarkers; D013859:Thiocarbamates; D050257:Tubulin Modulators; C066229:prolinedithiocarbamate; D014747:Vinblastine; D011392:Proline